FLT4 抗体
FLT4 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC, FACS, IF, ICC, IHC (fro) 宿主: 兔 Polyclonal unconjugated
FLT4 适用: 人 WB, FACS, IHC (p) 宿主: 小鼠 Monoclonal 818CT12-1-1 unconjugated
FLT4 抗体 by 适用
Find FLT4 抗体 for a variety of species such as anti-Human FLT4, anti-Mouse FLT4, anti-Cow FLT4. The species listed below are among those available. Click on a link to go to the corresponding products.
FLT4 抗体 by 抗体来源
Find FLT4 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
FLT4 抗体 by 克隆形成能力
Find available monoclonal or polyclonal FLT4 抗体. Click on a link to go to the corresponding products.
Popular FLT4 抗体
- (1)
- (7)
- (1)
- (4)
- (5)
- (5)
- (8)
- (3)
- (3)
- (4)
- (4)
- (2)
- (2)
- (2)
- (2)
- (2)
- (2)
- (3)
- (1)
- (1)
- (2)
Latest Publications for our FLT4 抗体
: "Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease." in: Laboratory investigation; a journal of technical methods and pathology, (2019) (PubMed).: "Transcriptional landscape of pulmonary lymphatic endothelial cells during fetal gestation." in: PLoS ONE, Vol. 14, Issue 5, pp. e0216795, (2019) (PubMed).
: "Lymphatic impairment leads to pulmonary tertiary lymphoid organ formation and alveolar damage." in: The Journal of clinical investigation, Vol. 129, Issue 6, pp. 2514-2526, (2019) (PubMed).
: "uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis." in: Nature communications, Vol. 9, Issue 1, pp. 5178, (2019) (PubMed).
: "VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis." in: EMBO molecular medicine, Vol. 9, Issue 6, pp. 750-769, (2018) (PubMed).
: "Mesenchymal Stromal Cells Inhibit Inflammatory Lymphangiogenesis in the Cornea by Suppressing Macrophage in a TSG-6-Dependent Manner." in: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 26, Issue 1, pp. 162-172, (2018) (PubMed).
: "Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms." in: Nature communications, Vol. 9, Issue 1, pp. 1296, (2018) (PubMed).
: "Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program." in: Nature communications, Vol. 9, Issue 1, pp. 1511, (2018) (PubMed).
: "Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 201, Issue 1, pp. 215-229, (2018) (PubMed).
: "HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling axis during vascular development." in: Nature communications, Vol. 9, Issue 1, pp. 2704, (2018) (PubMed).
Aliases for FLT4 抗体
fms related tyrosine kinase 4 (FLT4) 抗体FMS-like tyrosine kinase 4 (Flt4) 抗体
fms-related tyrosine kinase 4 (Flt4) 抗体
fms-related tyrosine kinase 4 (flt4) 抗体
AI323512 抗体
cb1059 抗体
Chy 抗体
Flt-4 抗体
FLT41 抗体
LMPH1A 抗体
PCL 抗体
VEGFR-3 抗体
VEGFR3 抗体
Vegfr3 抗体
